Lupus anticoagulants: First French interlaboratory etalonorme survey

American Journal of Clinical Pathology

Volumn 105, Issue 6, 1996, Pages 788-793

  Roussi, Jacqueline ^a,c   Roisin, Jean Paul ^b   Goguel, Alain ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Diagnostica Stago   (France)

^c RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Blood coagulation; Lupus anticoagulant; Partial thromboplastin time

Indexed keywords

LUPUS ANTICOAGULANT;

ANTIBODY DETECTION; ARTICLE; CASE REPORT; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; EDUCATION PROGRAM; FEMALE; FRANCE; GOOD LABORATORY PRACTICE; HEALTH CARE QUALITY; HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SCREENING TEST;

EID: 0029891599     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.6.788     Document Type: Article

References (19)

1. Triplett DA. Antiphospholipid antibodies and thrombosis: a consequence, coincidence or cause? Arch Pathol Lab Med 1993;117:77-88.
2. Galli M, Bevers EM. Inhibition of phospholipid-dependent coagulation reactions by "antiphospholipid antibodies": Possible modes of action. Lupus 1994;3:223-228.
3. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA. Lupus anticoagulant IgGs (LA) are not directed to phospholipids only but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991;66:629-632.
4. Conley CL, Hartmann RC. A haemorrhagic disorder caused by circulating anticoagulant in patients with systemic lupus erythematosus. J Clin Invest 1952;31:621-622.
5. Love PE, Santoro SA. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: Prevalence and clinical significance. Ann Intern Med 1990;112:682-698.
6. Ginsberg JS, Brill-Edwards P, Johnston M, et al. Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: A cross-sectional study. Blood 1992;80:975-980.
7. Harris EN. Diagnosis and management of antiphospholipid syndrome. Hosp Pract 1994;29:65-77.
8. Santoro SA. Antiphospholipid antibodies and thrombotic predisposition: Underlying pathogenic mechanisms. Blood 1994;83: 2389-2391.
9. Exner T, Triplett DA, Taberner D, Machin SJ. Guidelines for testing and revised criteria for lupus anticoagulants: SSC subcommittee for the standardization of lupus anticoagulant. Thromb Haemost 1991;65:320-322.
10. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: An update. Thromb Haemost 1995;74:1185-1191.
11. Goguel AF. French national external quality assessment program in coagulation testing: The Etalonorme experience. In: Triplett DA, ed. Advances in Coagulation Testing: Interpretation and Application. College of American Pathologists, 1986, pp 231-243.
12. Rosner E, Pauzner R, Lusky A, Modan M, Many A. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost 1987;57:144-147.
13. Exner T. Diagnostic methodologies for circulating anticoagulants. Thromb Haemost 1995;74:338-344.
14. Rauch J, Janoff AS. Phospholipid in the hexagonal II phase is immunogenic: Evidence for immunorecognition of non bilayer lipid phases in vivo. Proc Natl Acad Sci USA 1990;87:4112-4114.
15. Triplett DA, Brand JT, Kaczor D, Schaeffer J. Laboratory diagnosis of lupus inhibitors: A comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983;79:678-682.
16. Haemostasis Committee of the Société Française de Biologie Clinique. Laboratory heterogeneity of the lupus anticoagulant: A multicentre study using different clotting assays on a panel of 78 samples. Thromb Res 1992;66:349-364.
17. Working Group on Hemostasis of the "Société Française de Biologie Clinique." Comparison of a standardized procedure with current laboratory practices for the detection of lupus anticoagulant in France. Thromb Haemost 1993;70:781-786.
18. Arnout J, Vanrusselt M, Huybrechts E, Vermylen J. Optimization of the dilute prothrombin time for the detection of the lupus anticoagulant by use of a recombinant tissue thromboplastin. Br J Haematol 1994;87:94-99.
19. Caron C, Goudemand J, for the Working Group on Hemostasis of the "Société Française de Biologie Clinique." Sensitivity and specificity of tests and reagents used in the diagnosis of LA: A French multicenter study (Abstr). Lupus 1994;3:334.